Search results for "immune cell therapy"

From Bludgeon to Scalpel: ASCO 2026 Signals Oncology’s Shift From ‘Strong Chemo’ to ‘Right Chemo’

From Bludgeon to Scalpel: ASCO 2026 Signals Oncology’s Shift From ‘Strong Chemo’ to ‘Right Chemo’

The standard of care in cancer treatment is undergoing a rapid paradigm shift. For decades, the default oncological approach relied on aggressive...
Curocell’s Homegrown CAR-T Therapy Rimqarto Lands Spotlight in Top Hematology Journal Blood

Curocell’s Homegrown CAR-T Therapy Rimqarto Lands Spotlight in Top Hematology Journal Blood

Curocell, a South Korean clinical-stage biotech company specializing in chimeric antigen receptor T-cell (CAR-T) therapies, announced on June 15 that...
Celltrion Advances Next-Generation Immuno-Oncology Candidate with Strong Preclinical Results

Celltrion Advances Next-Generation Immuno-Oncology Candidate with Strong Preclinical Results

Celltrion has announced promising preclinical data for its investigational immuno-oncology candidate, CT-P72/ABP-102,...
Can Guava Juice Fight Anemia? New Study Shows Significant Hemoglobin Boost

Can Guava Juice Fight Anemia? New Study Shows Significant Hemoglobin Boost

Researchers at Aga Khan University in Pakistan recently published a comprehensive analysis evaluating the relationship...
Ebola spreads rapidly in DRC—how far have new vaccines and treatments come?

Ebola spreads rapidly in DRC—how far have new vaccines and treatments come?

A Reuters report said the U.K. media outlet The Guardian reported on the 19th (20th in Korea time) that the World...
Rznomics and Inha University Confirm Potential for In-Vivo CAR-T Delivery Technology

Rznomics and Inha University Confirm Potential for In-Vivo CAR-T Delivery Technology

Rznomics announced on the 30th that a joint study with Professor Hyun-jin Kim’s research team at Inha University has...
A Single Cancer Shot: Local Injection Triggers Systemic Tumor Disappearance

A Single Cancer Shot: Local Injection Triggers Systemic Tumor Disappearance

For decades, one immuno-oncology strategy has held immense promise while repeatedly falling short: the use of CD40...
Rznomics to Present Oral Report on Breakthrough Anti-Cancer Gene Therapy at AACR

Rznomics to Present Oral Report on Breakthrough Anti-Cancer Gene Therapy at AACR

Rznomics, a biotechnology company specializing in RNA-based gene therapies, announced on March 5 that it has been...
ABL Bio Publishes Review Paper on Dual Antibodies in International Journal

ABL Bio Publishes Review Paper on Dual Antibodies in International Journal

ABL Bio announced on the 11th that it published a review paper on the next-generation immune-oncology dual antibody...
The Vitamin Myth: Why More Isn’t Always Better for Your Health

The Vitamin Myth: Why More Isn’t Always Better for Your Health

There is a toxic substance in our bodies known as reactive oxygen species . Just as a car uses gasoline and oxygen to...